Growth Capital for a Telederm Provider of Customized Hair Medicine and Treatments
Who is Happy Head?
Happy Head is a telemedicine provider of dermatologist-prescribed, customized hair medicine and treatments for both men and women. Their proprietary hair growth formulas were developed by world-renowned hair loss pioneers to include the strongest FDA-approved prescription ingredients available. Happy Head’s core flagship product is a customizable topical treatment that’s applied directly to the scalp, including optional ingredients such as: Finasteride, Dutasteride, Spironolactone, Minoxidil, Retinoic Acid, and Hydrocortisone.
Happy Head also offers a wide range of oral medications including the market’s first and only 3-in-1 SuperCapsule™ that combines ingredients Finasteride (or Dutasteride), Minoxidil, and Vitamin D3 in a single daily capsule. In addition, patients have the option to supercharge their medication with non-prescription products such as Happy Head’s Thickening Shampoo and Conditioner, as well as daily Hair Supplements.
Happy Head, experiencing tremendous traction in the telehealth space, was seeking a capital partner to support its ongoing growth initiatives.
Hum’s Strategic Capital team worked with Happy Head to build a committed Promissory Note facility designed to help facilitate their immediate growth plans and trajectory. The facility was structured to support expenses including marketing, hiring, and other growth-related expenses.
Hum Capital was instrumental in helping us explore paths to fund our exponential growth. Their team truly took the time to understand our market, mission, vision, and product offering. With Hum Capital, we quickly found an optimal growth capital solution and a trusted long-term partner.